Skip to main content
. 2011 Oct;85(19):10109–10116. doi: 10.1128/JVI.05341-11

Table 1.

Primer sequences used in relative quantification real-time PCR assays

Gene Sequence (5′→3′)a Amplification product length (bp)
CCR1 F, ACCATAGGAGGCCAACCCAAAATA 103
R, TCCATGCTGTGCCAAGAGTCA
CCR2 F, CTACCTTCCAGTTCCTCATTTTT 100
R, ACATTTACAAGTTGCAGTTTTCAGC
CCR3 F, TTTGTCATCATGGCGGTGTTTTTC 169
R, GGTTCATGCAGCAGTGGGAGTAG
CCR4 F, GAGAAGAAGAACAAGGCGGTGAAGA 200
R, GGATTAAGGCAGCAGTGAACAAAAG
CCR5 F, CAACCACAGGCAGCATTTAGCAC 147
R, GGCAGGCAGCATCTTAGTTTTTCAG
CCR6 F, CTGCCTGAACCCTGTGCTCTACG 171
R, TTATCTGCGGTCTCACTGGTCTGC
CCR7 F, GCCGAGACCACCACCACCTT 105
R, AGTCATTGCATCTGCTCCCTATCC
CCR10 F, GGGCTGGAGTCTGGGAAGTGC 183
R, ACGATGACGGAGACCAAGTGTGC
CCR11 F, TCCTCCCTGTATTCCTCACAATAG 310
R, CTGGGGACTTTAGTTACTGCCAC
CXCR1 F, CTGAGCCCCAAGTGGAACGAGACA 152
R, GCACGGAACAGAAGCTTTATTAGGA
CXCR2 F, CAATGAATGAATGAATGGCTAAG 118
R, AAAGTTTTCAAGGTTCGTCCGTGTT
CXCR3 F, CCCGCAACTGGTGCCGAGAAAG 148
R, AGGCGCAAGAGCAGCATCCACAT
CXCR4 F, ATCCCTGCCCTCCTGCTGACTATTC 231
R, GAGGGCCTTGCGCTTCTGGTG
CXCR5 F, TCCCCTCCTCACTCCCTTCCCATAA 224
R, CCTGCGGTTCCATCTGAGTGACATC
CXCR6 F, TTGTTTATAGCTTGCGCATTCTCAT 189
R, ATCCCCCTTGGTTTCAGCATTCTT
β-Actin F, GGATGCAGAAGGAGATCACTG 90
R, CAAGTACTCCGTGTGGATCG
a

F, forward; R, reverse.

HHS Vulnerability Disclosure